Innoviva, Inc. Files 8-K on Financials
Ticker: INVA · Form: 8-K · Filed: Jul 31, 2024 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Innoviva dropped its 8-K on July 31st, check the financials!
AI Summary
Innoviva, Inc. filed an 8-K on July 31, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 1350 Old Bayshore Highway, Suite 400, Burlingame, California.
Why It Matters
This 8-K filing provides investors with updated financial information and operational results for Innoviva, Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any unusual risks or events.
Key Players & Entities
- Innoviva, Inc. (company) — Registrant
- July 31, 2024 (date) — Date of earliest event reported
- 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010 (location) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Innoviva, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was filed as of July 31, 2024.
What is Innoviva, Inc.'s principal business address?
Innoviva, Inc.'s principal executive offices are located at 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010.
What is Innoviva, Inc.'s state of incorporation?
Innoviva, Inc. is incorporated in Delaware.
What is Innoviva, Inc.'s IRS Employer Identification Number?
Innoviva, Inc.'s IRS Employer Identification Number is 94-3265960.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-07-31 16:17:15
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share INVA The Nasdaq Stock Mar
Filing Documents
- tm2420507d1_8k.htm (8-K) — 23KB
- tm2420507d1_ex99-1.htm (EX-99.1) — 112KB
- tm2420507d1_ex99-1img01.jpg (GRAPHIC) — 4KB
- 0001104659-24-084357.txt ( ) — 323KB
- inva-20240731.xsd (EX-101.SCH) — 3KB
- inva-20240731_lab.xml (EX-101.LAB) — 33KB
- inva-20240731_pre.xml (EX-101.PRE) — 22KB
- tm2420507d1_8k_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On July 31, 2024, Innoviva, Inc. (the "Company") issued a press release regarding its results of operations and financial condition for the quarter ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits 99.1 Press Release dated July 31, 2024 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document) - 2 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVIVA, INC. Date: July 31, 2024 By: /s/ Pavel Raifeld Pavel Raifeld Chief Executive Officer - 3 -